These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 7719272)

  • 1. Liposomes as delivery systems in the prevention and treatment of infectious diseases.
    Bergers JJ; ten Hagen TL; van Etten EW; Bakker-Woudenberg IA
    Pharm World Sci; 1995 Jan; 17(1):1-11. PubMed ID: 7719272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes in treatment of infectious diseases.
    Emmen F; Storm G
    Pharm Weekbl Sci; 1987 Jun; 9(3):162-71. PubMed ID: 3302929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal vaccine delivery systems.
    Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
    Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides.
    Karlowsky JA; Zhanel GG
    Clin Infect Dis; 1992 Oct; 15(4):654-67. PubMed ID: 1420679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes and lipid carriers in the treatment of microbial infections.
    Bakker-Woudenberg IA; Lokerse AF
    Scand J Infect Dis Suppl; 1990; 74():34-41. PubMed ID: 2097717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug delivery system for infectious diseases].
    Maesaki S; Kohno S
    Nihon Rinsho; 1998 Mar; 56(3):752-61. PubMed ID: 9549369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of liposomal drug delivery.
    Szoka FC
    Biotechnol Appl Biochem; 1990 Oct; 12(5):496-500. PubMed ID: 2288703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal adjuvants for human vaccines.
    Alving CR; Beck Z; Matyas GR; Rao M
    Expert Opin Drug Deliv; 2016 Jun; 13(6):807-16. PubMed ID: 26866300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.
    Bakker-Woudenberg IA; Lokerse AF; ten Kate MT; Melissen PM; van Vianen W; van Etten EW
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S61-7. PubMed ID: 8477767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies.
    Schiffelers R; Storm G; Bakker-Woudenberg I
    J Antimicrob Chemother; 2001 Sep; 48(3):333-44. PubMed ID: 11532996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Felnerova D; Viret JF; Glück R; Moser C
    Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Storm G; Woodle MC
    J Drug Target; 1994; 2(5):363-71. PubMed ID: 7704480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
    Richards RL; Alving CR; Wassef NM
    J Pharm Sci; 1996 Dec; 85(12):1286-9. PubMed ID: 8961140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes in the treatment of malignancy: a clinical perspective.
    Sugarman SM; Perez-Soler R
    Crit Rev Oncol Hematol; 1992; 12(3):231-42. PubMed ID: 1497823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.
    Watson DS; Endsley AN; Huang L
    Vaccine; 2012 Mar; 30(13):2256-72. PubMed ID: 22306376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing liposomal adjuvants for the next generation of vaccines.
    Perrie Y; Crofts F; Devitt A; Griffiths HR; Kastner E; Nadella V
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):85-96. PubMed ID: 26576719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal antibiotics for the treatment of infectious diseases.
    Alhariri M; Azghani A; Omri A
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical design of the liposomal antimicrobial agents for infectious disease.
    Moribe K; Maruyama K
    Curr Pharm Des; 2002; 8(6):441-54. PubMed ID: 12069381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunological adjuvant and vaccine carrier properties of liposomes.
    Gregoriadis G
    J Drug Target; 1994; 2(5):351-6. PubMed ID: 7704478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.